Table 3.
Comparison of clinical presentation between pituitary apoplexy cases (n = 121) and controls (n = 242)
| Symptom/sign | Pituitary apoplexy (n = 121) | control (n = 242) | P | ||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Headache | 87 | 71.9 | 130 | 53.7 | 0.001* |
| Vomiting | 23 | 19.0 | 14 | 5.80 | 0.000* |
| Fever | 3 | 2.5 | 5 | 2.10 | 0.800* |
| Visual impairment | 80 | 66.1 | 155 | 64.0 | 0.698* |
| Diplopia | 2 | 1.7 | 7 | 2.90 | 0.474* |
| Ablepsia | 12 | 10.0 | 11 | 4.50 | 0.045* |
| Visual field defect | 51 | 50.4 | 124 | 51.20 | 0.882* |
| Acromegaly | 5 | 4.1 | 18 | 7.40 | 0.223* |
| Cushingoid appearance | 0 | 0 | 4 | 1.7 | 0.356† |
| Sexual hypoactivityb | 0 | 0 | 3 | 1.2 | 0.463† |
| Hypopituitarism | 20 | 16.5 | 28 | 11.6 | 0.189* |
| Hypothyroidism | 32 | 26.45 | 31 | 12.81 | 0.001* |
| Amenorrheaa | 16 | 15.84 | 72 | 12.57 | 0.542* |
| Altered menstrual cyclea | 14 | 11.57 | 26 | 10.74 | 0.406* |
| Galactorrhoeaa | 19 | 15.70 | 23 | 9.50 | 0.026* |
| Gynecomastiab | 0 | 0 | 0 | 0 | – |
*Pearson’s chi-squared test
aThese calculations include only women
†Pearson’s statistic with a continuity correction
bThese calculations include only men